Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW – Free Report) was the recipient of a significant drop in short interest in June. As of June 15th, there was short interest totalling 100 shares, a drop of 50.0% from the May 31st total of 200 shares. Based on an average daily volume of 2,500 shares, the days-to-cover ratio is […]
Research analysts at StockNews.com initiated coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other analysts have also recently issued reports on the company. William Blair reiterated an “outperform” […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) had its price target trimmed by Chardan Capital from $63.00 to $61.00 in a report issued on Friday morning, The Fly reports. Several other analysts also recently issued reports on the stock. Needham & Company LLC reaffirmed a buy rating and set a $60.00 price objective on shares of […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.73) earnings per share for the quarter, beating the consensus estimate of ($0.84) by $0.11, Briefing.com reports. During the same period last year, the company earned ($0.67) earnings per share. Rocket Pharmaceuticals Price Performance Shares of RCKT stock […]
StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) to a sell rating in a research report report published on Wednesday morning. A number of other equities analysts have also issued reports on RCKT. Morgan Stanley assumed coverage on shares of Rocket Pharmaceuticals in a research report on Wednesday, February 1st. They set an […]